nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—HCN3—Parkinson's disease	0.695	0.921	CbGaD
Dronedarone—CYP2D6—Parkinson's disease	0.035	0.0464	CbGaD
Dronedarone—ABCB1—Parkinson's disease	0.025	0.0331	CbGaD
Dronedarone—CACNA1S—pes—Parkinson's disease	0.00795	0.0941	CbGeAlD
Dronedarone—HCN1—forebrain—Parkinson's disease	0.00282	0.0334	CbGeAlD
Dronedarone—HCN4—forebrain—Parkinson's disease	0.00214	0.0253	CbGeAlD
Dronedarone—HCN4—cardiovascular system—Parkinson's disease	0.00181	0.0214	CbGeAlD
Dronedarone—HCN3—forebrain—Parkinson's disease	0.00173	0.0204	CbGeAlD
Dronedarone—HCN2—forebrain—Parkinson's disease	0.00162	0.0192	CbGeAlD
Dronedarone—HCN1—head—Parkinson's disease	0.00161	0.0191	CbGeAlD
Dronedarone—HCN1—nervous system—Parkinson's disease	0.00153	0.0181	CbGeAlD
Dronedarone—HCN1—central nervous system—Parkinson's disease	0.00147	0.0174	CbGeAlD
Dronedarone—HCN2—cardiovascular system—Parkinson's disease	0.00137	0.0162	CbGeAlD
Dronedarone—HCN3—medulla oblongata—Parkinson's disease	0.00125	0.0148	CbGeAlD
Dronedarone—HCN4—head—Parkinson's disease	0.00122	0.0145	CbGeAlD
Dronedarone—HCN2—medulla oblongata—Parkinson's disease	0.00117	0.0138	CbGeAlD
Dronedarone—HCN1—brain—Parkinson's disease	0.00117	0.0138	CbGeAlD
Dronedarone—HCN4—nervous system—Parkinson's disease	0.00116	0.0137	CbGeAlD
Dronedarone—HCN3—midbrain—Parkinson's disease	0.00114	0.0135	CbGeAlD
Dronedarone—HCN4—central nervous system—Parkinson's disease	0.00112	0.0132	CbGeAlD
Dronedarone—HCN2—midbrain—Parkinson's disease	0.00107	0.0126	CbGeAlD
Dronedarone—CACNB4—forebrain—Parkinson's disease	0.00106	0.0126	CbGeAlD
Dronedarone—HCN2—spinal cord—Parkinson's disease	0.00104	0.0123	CbGeAlD
Dronedarone—HCN3—head—Parkinson's disease	0.000989	0.0117	CbGeAlD
Dronedarone—SCN1A—hindbrain—Parkinson's disease	0.000963	0.0114	CbGeAlD
Dronedarone—HCN3—nervous system—Parkinson's disease	0.000937	0.0111	CbGeAlD
Dronedarone—CACNA1F—head—Parkinson's disease	0.000927	0.011	CbGeAlD
Dronedarone—HCN2—head—Parkinson's disease	0.000927	0.011	CbGeAlD
Dronedarone—HCN3—central nervous system—Parkinson's disease	0.000903	0.0107	CbGeAlD
Dronedarone—HCN4—brain—Parkinson's disease	0.000886	0.0105	CbGeAlD
Dronedarone—HCN3—cerebellum—Parkinson's disease	0.000882	0.0104	CbGeAlD
Dronedarone—HCN2—nervous system—Parkinson's disease	0.000878	0.0104	CbGeAlD
Dronedarone—CACNB1—forebrain—Parkinson's disease	0.00085	0.0101	CbGeAlD
Dronedarone—HCN2—central nervous system—Parkinson's disease	0.000846	0.01	CbGeAlD
Dronedarone—HCN2—cerebellum—Parkinson's disease	0.000827	0.00979	CbGeAlD
Dronedarone—CACNB3—forebrain—Parkinson's disease	0.000815	0.00965	CbGeAlD
Dronedarone—CACNA1S—cardiovascular system—Parkinson's disease	0.000771	0.00912	CbGeAlD
Dronedarone—CACNB4—medulla oblongata—Parkinson's disease	0.000769	0.0091	CbGeAlD
Dronedarone—CACNB1—cardiovascular system—Parkinson's disease	0.000719	0.00851	CbGeAlD
Dronedarone—HCN3—brain—Parkinson's disease	0.000717	0.00848	CbGeAlD
Dronedarone—CACNB4—midbrain—Parkinson's disease	0.000703	0.00832	CbGeAlD
Dronedarone—CACNB4—spinal cord—Parkinson's disease	0.000686	0.00812	CbGeAlD
Dronedarone—HCN2—brain—Parkinson's disease	0.000671	0.00795	CbGeAlD
Dronedarone—ADRA2A—peripheral nervous system—Parkinson's disease	0.000642	0.0076	CbGeAlD
Dronedarone—CACNB1—medulla oblongata—Parkinson's disease	0.000614	0.00727	CbGeAlD
Dronedarone—CACNB4—head—Parkinson's disease	0.000609	0.00721	CbGeAlD
Dronedarone—CACNB3—medulla oblongata—Parkinson's disease	0.000589	0.00697	CbGeAlD
Dronedarone—CACNB4—nervous system—Parkinson's disease	0.000578	0.00684	CbGeAlD
Dronedarone—CACNB1—midbrain—Parkinson's disease	0.000561	0.00664	CbGeAlD
Dronedarone—CACNB4—central nervous system—Parkinson's disease	0.000556	0.00659	CbGeAlD
Dronedarone—SCN1A—brainstem—Parkinson's disease	0.000552	0.00653	CbGeAlD
Dronedarone—CACNB1—spinal cord—Parkinson's disease	0.000548	0.00648	CbGeAlD
Dronedarone—CACNB4—cerebellum—Parkinson's disease	0.000544	0.00644	CbGeAlD
Dronedarone—CACNB3—midbrain—Parkinson's disease	0.000538	0.00637	CbGeAlD
Dronedarone—SCN1A—forebrain—Parkinson's disease	0.000532	0.0063	CbGeAlD
Dronedarone—ADRA1A—hindbrain—Parkinson's disease	0.000493	0.00583	CbGeAlD
Dronedarone—CACNB1—head—Parkinson's disease	0.000487	0.00576	CbGeAlD
Dronedarone—CACNA1D—forebrain—Parkinson's disease	0.000479	0.00567	CbGeAlD
Dronedarone—ADRA1D—forebrain—Parkinson's disease	0.000475	0.00562	CbGeAlD
Dronedarone—CACNB3—head—Parkinson's disease	0.000467	0.00553	CbGeAlD
Dronedarone—CACNB2—cardiovascular system—Parkinson's disease	0.000463	0.00548	CbGeAlD
Dronedarone—CACNB1—nervous system—Parkinson's disease	0.000461	0.00546	CbGeAlD
Dronedarone—CACNB1—central nervous system—Parkinson's disease	0.000444	0.00526	CbGeAlD
Dronedarone—CACNB3—nervous system—Parkinson's disease	0.000443	0.00524	CbGeAlD
Dronedarone—CACNA1C—forebrain—Parkinson's disease	0.000442	0.00523	CbGeAlD
Dronedarone—CACNB4—brain—Parkinson's disease	0.000442	0.00523	CbGeAlD
Dronedarone—CACNB1—cerebellum—Parkinson's disease	0.000434	0.00514	CbGeAlD
Dronedarone—CACNB3—central nervous system—Parkinson's disease	0.000426	0.00504	CbGeAlD
Dronedarone—CACNB3—cerebellum—Parkinson's disease	0.000417	0.00493	CbGeAlD
Dronedarone—CACNA1D—cardiovascular system—Parkinson's disease	0.000405	0.00479	CbGeAlD
Dronedarone—KCNK2—brain—Parkinson's disease	0.000392	0.00464	CbGeAlD
Dronedarone—SCN1A—medulla oblongata—Parkinson's disease	0.000385	0.00455	CbGeAlD
Dronedarone—CACNA1C—cardiovascular system—Parkinson's disease	0.000374	0.00442	CbGeAlD
Dronedarone—CACNB1—brain—Parkinson's disease	0.000353	0.00418	CbGeAlD
Dronedarone—SCN1A—midbrain—Parkinson's disease	0.000352	0.00416	CbGeAlD
Dronedarone—ADRB1—forebrain—Parkinson's disease	0.000345	0.00408	CbGeAlD
Dronedarone—SCN1A—spinal cord—Parkinson's disease	0.000343	0.00406	CbGeAlD
Dronedarone—CACNB3—brain—Parkinson's disease	0.000338	0.004	CbGeAlD
Dronedarone—CACNB2—head—Parkinson's disease	0.000314	0.00371	CbGeAlD
Dronedarone—SCN1A—head—Parkinson's disease	0.000305	0.00361	CbGeAlD
Dronedarone—CACNB2—nervous system—Parkinson's disease	0.000297	0.00352	CbGeAlD
Dronedarone—ADRB1—cardiovascular system—Parkinson's disease	0.000292	0.00345	CbGeAlD
Dronedarone—CYP2D6—hindbrain—Parkinson's disease	0.00029	0.00344	CbGeAlD
Dronedarone—SCN1A—nervous system—Parkinson's disease	0.000289	0.00342	CbGeAlD
Dronedarone—CACNB2—central nervous system—Parkinson's disease	0.000286	0.00339	CbGeAlD
Dronedarone—ADRA1A—brainstem—Parkinson's disease	0.000283	0.00334	CbGeAlD
Dronedarone—CACNB2—cerebellum—Parkinson's disease	0.00028	0.00331	CbGeAlD
Dronedarone—SCN1A—central nervous system—Parkinson's disease	0.000278	0.00329	CbGeAlD
Dronedarone—ADRA1B—head—Parkinson's disease	0.000278	0.00329	CbGeAlD
Dronedarone—CACNA1D—head—Parkinson's disease	0.000274	0.00325	CbGeAlD
Dronedarone—ADRA1A—forebrain—Parkinson's disease	0.000273	0.00323	CbGeAlD
Dronedarone—SCN1A—cerebellum—Parkinson's disease	0.000272	0.00322	CbGeAlD
Dronedarone—ADRA1D—head—Parkinson's disease	0.000272	0.00322	CbGeAlD
Dronedarone—ADRA1B—nervous system—Parkinson's disease	0.000263	0.00312	CbGeAlD
Dronedarone—KCNH2—forebrain—Parkinson's disease	0.000263	0.00312	CbGeAlD
Dronedarone—CACNA1D—nervous system—Parkinson's disease	0.00026	0.00308	CbGeAlD
Dronedarone—ADRA1D—nervous system—Parkinson's disease	0.000258	0.00305	CbGeAlD
Dronedarone—Amiodarone—CYP2D6—Parkinson's disease	0.000257	0.583	CrCbGaD
Dronedarone—ADRA1B—central nervous system—Parkinson's disease	0.000254	0.003	CbGeAlD
Dronedarone—CACNA1C—head—Parkinson's disease	0.000253	0.003	CbGeAlD
Dronedarone—CACNA1D—central nervous system—Parkinson's disease	0.00025	0.00296	CbGeAlD
Dronedarone—ADRA1D—central nervous system—Parkinson's disease	0.000248	0.00294	CbGeAlD
Dronedarone—CACNA1D—cerebellum—Parkinson's disease	0.000245	0.0029	CbGeAlD
Dronedarone—CACNA1C—nervous system—Parkinson's disease	0.00024	0.00284	CbGeAlD
Dronedarone—CACNA1C—central nervous system—Parkinson's disease	0.000231	0.00273	CbGeAlD
Dronedarone—ADRA1A—cardiovascular system—Parkinson's disease	0.000231	0.00273	CbGeAlD
Dronedarone—CACNB2—brain—Parkinson's disease	0.000227	0.00269	CbGeAlD
Dronedarone—CACNA1C—cerebellum—Parkinson's disease	0.000226	0.00267	CbGeAlD
Dronedarone—KCNH2—cardiovascular system—Parkinson's disease	0.000223	0.00264	CbGeAlD
Dronedarone—SCN1A—brain—Parkinson's disease	0.000221	0.00262	CbGeAlD
Dronedarone—ADRA2A—forebrain—Parkinson's disease	0.000207	0.00245	CbGeAlD
Dronedarone—ADRA1B—brain—Parkinson's disease	0.000201	0.00238	CbGeAlD
Dronedarone—CACNA1D—brain—Parkinson's disease	0.000199	0.00235	CbGeAlD
Dronedarone—ADRB1—head—Parkinson's disease	0.000197	0.00234	CbGeAlD
Dronedarone—ADRA1D—brain—Parkinson's disease	0.000197	0.00233	CbGeAlD
Dronedarone—KCNH2—medulla oblongata—Parkinson's disease	0.00019	0.00225	CbGeAlD
Dronedarone—ADRA2C—medulla oblongata—Parkinson's disease	0.000188	0.00222	CbGeAlD
Dronedarone—ADRB1—nervous system—Parkinson's disease	0.000187	0.00222	CbGeAlD
Dronedarone—Amiodarone—ABCB1—Parkinson's disease	0.000184	0.416	CrCbGaD
Dronedarone—CACNA1C—brain—Parkinson's disease	0.000183	0.00217	CbGeAlD
Dronedarone—ADRB1—central nervous system—Parkinson's disease	0.00018	0.00213	CbGeAlD
Dronedarone—KCNH2—midbrain—Parkinson's disease	0.000174	0.00206	CbGeAlD
Dronedarone—ADRA2C—midbrain—Parkinson's disease	0.000172	0.00203	CbGeAlD
Dronedarone—KCNH2—spinal cord—Parkinson's disease	0.00017	0.00201	CbGeAlD
Dronedarone—ADRA2C—spinal cord—Parkinson's disease	0.000167	0.00198	CbGeAlD
Dronedarone—CYP2D6—brainstem—Parkinson's disease	0.000166	0.00197	CbGeAlD
Dronedarone—CYP2D6—forebrain—Parkinson's disease	0.000161	0.0019	CbGeAlD
Dronedarone—ADRA1A—head—Parkinson's disease	0.000156	0.00185	CbGeAlD
Dronedarone—KCNH2—head—Parkinson's disease	0.000151	0.00178	CbGeAlD
Dronedarone—ADRA2A—medulla oblongata—Parkinson's disease	0.00015	0.00177	CbGeAlD
Dronedarone—ADRA2C—head—Parkinson's disease	0.000149	0.00176	CbGeAlD
Dronedarone—ADRA1A—nervous system—Parkinson's disease	0.000148	0.00175	CbGeAlD
Dronedarone—ADRB1—brain—Parkinson's disease	0.000143	0.00169	CbGeAlD
Dronedarone—KCNH2—nervous system—Parkinson's disease	0.000143	0.00169	CbGeAlD
Dronedarone—ADRA1A—central nervous system—Parkinson's disease	0.000143	0.00169	CbGeAlD
Dronedarone—ALB—brain—Parkinson's disease	0.000142	0.00168	CbGeAlD
Dronedarone—ADRA2C—nervous system—Parkinson's disease	0.000141	0.00167	CbGeAlD
Dronedarone—ADRA1A—cerebellum—Parkinson's disease	0.000139	0.00165	CbGeAlD
Dronedarone—KCNH2—central nervous system—Parkinson's disease	0.000138	0.00163	CbGeAlD
Dronedarone—ADRA2A—midbrain—Parkinson's disease	0.000137	0.00162	CbGeAlD
Dronedarone—ADRA2C—central nervous system—Parkinson's disease	0.000136	0.00161	CbGeAlD
Dronedarone—KCNH2—cerebellum—Parkinson's disease	0.000135	0.00159	CbGeAlD
Dronedarone—ADRA2A—spinal cord—Parkinson's disease	0.000134	0.00158	CbGeAlD
Dronedarone—ADRA2C—cerebellum—Parkinson's disease	0.000133	0.00157	CbGeAlD
Dronedarone—ABCB1—embryo—Parkinson's disease	0.000131	0.00155	CbGeAlD
Dronedarone—ADRA2A—head—Parkinson's disease	0.000119	0.00141	CbGeAlD
Dronedarone—ABCB1—forebrain—Parkinson's disease	0.000116	0.00137	CbGeAlD
Dronedarone—ADRA1A—brain—Parkinson's disease	0.000113	0.00134	CbGeAlD
Dronedarone—ADRA2A—nervous system—Parkinson's disease	0.000113	0.00133	CbGeAlD
Dronedarone—KCNH2—brain—Parkinson's disease	0.000109	0.00129	CbGeAlD
Dronedarone—ADRA2A—central nervous system—Parkinson's disease	0.000108	0.00128	CbGeAlD
Dronedarone—ADRA2C—brain—Parkinson's disease	0.000108	0.00128	CbGeAlD
Dronedarone—ADRA2A—cerebellum—Parkinson's disease	0.000106	0.00125	CbGeAlD
Dronedarone—ABCB1—cardiovascular system—Parkinson's disease	9.77e-05	0.00116	CbGeAlD
Dronedarone—CYP2D6—head—Parkinson's disease	9.2e-05	0.00109	CbGeAlD
Dronedarone—CYP3A4—nervous system—Parkinson's disease	8.86e-05	0.00105	CbGeAlD
Dronedarone—CYP2D6—nervous system—Parkinson's disease	8.72e-05	0.00103	CbGeAlD
Dronedarone—ADRA2A—brain—Parkinson's disease	8.6e-05	0.00102	CbGeAlD
Dronedarone—CYP3A4—central nervous system—Parkinson's disease	8.53e-05	0.00101	CbGeAlD
Dronedarone—CYP2D6—central nervous system—Parkinson's disease	8.39e-05	0.000994	CbGeAlD
Dronedarone—ABCB1—medulla oblongata—Parkinson's disease	8.35e-05	0.000988	CbGeAlD
Dronedarone—CYP2D6—cerebellum—Parkinson's disease	8.2e-05	0.000971	CbGeAlD
Dronedarone—ABCB1—midbrain—Parkinson's disease	7.63e-05	0.000903	CbGeAlD
Dronedarone—ABCB1—spinal cord—Parkinson's disease	7.44e-05	0.000881	CbGeAlD
Dronedarone—CYP2D6—brain—Parkinson's disease	6.66e-05	0.000789	CbGeAlD
Dronedarone—ABCB1—head—Parkinson's disease	6.61e-05	0.000783	CbGeAlD
Dronedarone—ABCB1—nervous system—Parkinson's disease	6.27e-05	0.000742	CbGeAlD
Dronedarone—ABCB1—central nervous system—Parkinson's disease	6.04e-05	0.000715	CbGeAlD
Dronedarone—ABCB1—cerebellum—Parkinson's disease	5.9e-05	0.000699	CbGeAlD
Dronedarone—ABCB1—brain—Parkinson's disease	4.79e-05	0.000567	CbGeAlD
Dronedarone—CACNA1C—Developmental Biology—IL6—Parkinson's disease	4.66e-06	2.9e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	4.65e-06	2.9e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—DDC—Parkinson's disease	4.65e-06	2.9e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—ADRBK1—Parkinson's disease	4.64e-06	2.89e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—DRD1—Parkinson's disease	4.63e-06	2.89e-05	CbGpPWpGaD
Dronedarone—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.62e-06	2.88e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—TH—Parkinson's disease	4.61e-06	2.88e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—EDN1—Parkinson's disease	4.59e-06	2.87e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.59e-06	2.86e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	4.53e-06	2.82e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	4.51e-06	2.82e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PLA2G6—Parkinson's disease	4.51e-06	2.81e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—FGB—Parkinson's disease	4.5e-06	2.81e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HTR7—Parkinson's disease	4.49e-06	2.8e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—DRD2—Parkinson's disease	4.49e-06	2.8e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—HTR2A—Parkinson's disease	4.49e-06	2.8e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	4.49e-06	2.8e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—DRD3—Parkinson's disease	4.49e-06	2.8e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HTR1A—Parkinson's disease	4.48e-06	2.79e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—MAOB—Parkinson's disease	4.46e-06	2.78e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—FGB—Parkinson's disease	4.43e-06	2.76e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—CYCS—Parkinson's disease	4.43e-06	2.76e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—HTR2A—Parkinson's disease	4.42e-06	2.76e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TAC1—Parkinson's disease	4.41e-06	2.75e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HTR1A—Parkinson's disease	4.41e-06	2.75e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTA4—Parkinson's disease	4.39e-06	2.74e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—DDC—Parkinson's disease	4.38e-06	2.73e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.38e-06	2.73e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TAC1—Parkinson's disease	4.34e-06	2.71e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—DRD1—Parkinson's disease	4.33e-06	2.7e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	4.33e-06	2.7e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—FGF20—Parkinson's disease	4.32e-06	2.7e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—DRD1—Parkinson's disease	4.26e-06	2.66e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.25e-06	2.65e-05	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—INS—Parkinson's disease	4.24e-06	2.64e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	4.23e-06	2.64e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CYP2D6—Parkinson's disease	4.2e-06	2.62e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ADORA2A—Parkinson's disease	4.19e-06	2.62e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—DRD3—Parkinson's disease	4.19e-06	2.61e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—ADRBK1—Parkinson's disease	4.19e-06	2.61e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—EDN1—Parkinson's disease	4.17e-06	2.6e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	4.17e-06	2.6e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.13e-06	2.58e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CTGF—Parkinson's disease	4.13e-06	2.57e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—DRD3—Parkinson's disease	4.12e-06	2.57e-05	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	4.12e-06	2.57e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	4.09e-06	2.55e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	4.09e-06	2.55e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—DRD2—Parkinson's disease	4.06e-06	2.53e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HTR7—Parkinson's disease	4.06e-06	2.53e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	4.02e-06	2.51e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PLA2G6—Parkinson's disease	3.95e-06	2.46e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	3.94e-06	2.46e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	3.93e-06	2.45e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—COMT—Parkinson's disease	3.92e-06	2.45e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	3.92e-06	2.44e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—ADRBK1—Parkinson's disease	3.91e-06	2.44e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—MAOB—Parkinson's disease	3.91e-06	2.44e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—GSTP1—Parkinson's disease	3.9e-06	2.43e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GBA—Parkinson's disease	3.9e-06	2.43e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—DBH—Parkinson's disease	3.9e-06	2.43e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.9e-06	2.43e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—MAOA—Parkinson's disease	3.89e-06	2.43e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	3.87e-06	2.41e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	3.86e-06	2.41e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	3.85e-06	2.4e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—HMOX1—Parkinson's disease	3.85e-06	2.4e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	3.84e-06	2.4e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—NQO1—Parkinson's disease	3.8e-06	2.37e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HTR7—Parkinson's disease	3.79e-06	2.36e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—DRD2—Parkinson's disease	3.79e-06	2.36e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	3.78e-06	2.36e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IGF2—Parkinson's disease	3.77e-06	2.35e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—TH—Parkinson's disease	3.75e-06	2.34e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	3.73e-06	2.33e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	3.73e-06	2.33e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.72e-06	2.32e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—ABCB1—Parkinson's disease	3.69e-06	2.3e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.68e-06	2.3e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	3.66e-06	2.28e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	3.66e-06	2.28e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	3.65e-06	2.28e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	3.64e-06	2.27e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	3.64e-06	2.27e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	3.6e-06	2.24e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CYCS—Parkinson's disease	3.6e-06	2.24e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—GSTM1—Parkinson's disease	3.59e-06	2.24e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	3.58e-06	2.24e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	3.51e-06	2.19e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—GPX1—Parkinson's disease	3.43e-06	2.14e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	3.43e-06	2.14e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	3.42e-06	2.13e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	3.4e-06	2.12e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	3.4e-06	2.12e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	3.32e-06	2.07e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYP2D6—Parkinson's disease	3.32e-06	2.07e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	3.31e-06	2.07e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	3.31e-06	2.07e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	3.31e-06	2.06e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	3.29e-06	2.05e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	3.28e-06	2.04e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CTGF—Parkinson's disease	3.26e-06	2.03e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	3.25e-06	2.03e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—COMT—Parkinson's disease	3.19e-06	1.99e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	3.18e-06	1.98e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	3.18e-06	1.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—GSTP1—Parkinson's disease	3.17e-06	1.98e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—MTHFR—Parkinson's disease	3.17e-06	1.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—MAOA—Parkinson's disease	3.16e-06	1.97e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	3.15e-06	1.96e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—HMOX1—Parkinson's disease	3.13e-06	1.95e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	3.13e-06	1.95e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	3.08e-06	1.92e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	3.08e-06	1.92e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	3.07e-06	1.92e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	3.03e-06	1.89e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYP2E1—Parkinson's disease	3.03e-06	1.89e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	3.02e-06	1.88e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NGF—Parkinson's disease	3.01e-06	1.88e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—ABCB1—Parkinson's disease	3e-06	1.87e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—NQO1—Parkinson's disease	3e-06	1.87e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	2.99e-06	1.86e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	2.98e-06	1.86e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—TH—Parkinson's disease	2.96e-06	1.84e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—APOE—Parkinson's disease	2.95e-06	1.84e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	2.93e-06	1.83e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—GSTM1—Parkinson's disease	2.91e-06	1.82e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.91e-06	1.81e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	2.87e-06	1.79e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—DDC—Parkinson's disease	2.86e-06	1.79e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CTGF—Parkinson's disease	2.85e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	2.84e-06	1.77e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYCS—Parkinson's disease	2.84e-06	1.77e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—GPX1—Parkinson's disease	2.79e-06	1.74e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	2.79e-06	1.74e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	2.78e-06	1.73e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	2.74e-06	1.71e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.7e-06	1.69e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.69e-06	1.68e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	2.68e-06	1.67e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—APOE—Parkinson's disease	2.67e-06	1.66e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.66e-06	1.66e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	2.65e-06	1.66e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	2.65e-06	1.65e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	2.64e-06	1.65e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—NQO1—Parkinson's disease	2.63e-06	1.64e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	2.61e-06	1.63e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—TH—Parkinson's disease	2.59e-06	1.62e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	2.58e-06	1.61e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—MTHFR—Parkinson's disease	2.57e-06	1.61e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—INS—Parkinson's disease	2.52e-06	1.57e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—COMT—Parkinson's disease	2.51e-06	1.57e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.5e-06	1.56e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GSTP1—Parkinson's disease	2.5e-06	1.56e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—INS—Parkinson's disease	2.5e-06	1.56e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—MAOA—Parkinson's disease	2.5e-06	1.56e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	2.49e-06	1.56e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYCS—Parkinson's disease	2.49e-06	1.55e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.48e-06	1.54e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	2.47e-06	1.54e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—HMOX1—Parkinson's disease	2.47e-06	1.54e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	2.46e-06	1.54e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—TH—Parkinson's disease	2.44e-06	1.52e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	2.44e-06	1.52e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.43e-06	1.52e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	2.43e-06	1.51e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.41e-06	1.5e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—APOE—Parkinson's disease	2.4e-06	1.5e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—ABCB1—Parkinson's disease	2.37e-06	1.48e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.34e-06	1.46e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	2.32e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GSTM1—Parkinson's disease	2.3e-06	1.43e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—INS—Parkinson's disease	2.28e-06	1.42e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	2.26e-06	1.41e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—INS—Parkinson's disease	2.26e-06	1.41e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—COMT—Parkinson's disease	2.2e-06	1.37e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GPX1—Parkinson's disease	2.2e-06	1.37e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.19e-06	1.37e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—MAOA—Parkinson's disease	2.19e-06	1.36e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.16e-06	1.35e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	2.16e-06	1.35e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	2.16e-06	1.34e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—INS—Parkinson's disease	2.11e-06	1.31e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—COMT—Parkinson's disease	2.08e-06	1.29e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—INS—Parkinson's disease	2.07e-06	1.29e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.07e-06	1.29e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.06e-06	1.29e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—INS—Parkinson's disease	2.05e-06	1.28e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.04e-06	1.27e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—MTHFR—Parkinson's disease	2.03e-06	1.27e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.01e-06	1.26e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	2e-06	1.25e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.96e-06	1.22e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GPX1—Parkinson's disease	1.93e-06	1.2e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.9e-06	1.18e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—APOE—Parkinson's disease	1.89e-06	1.18e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	1.86e-06	1.16e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	1.85e-06	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—INS—Parkinson's disease	1.84e-06	1.15e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.82e-06	1.13e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.79e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.78e-06	1.11e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.76e-06	1.1e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—INS—Parkinson's disease	1.71e-06	1.07e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	1.71e-06	1.07e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.7e-06	1.06e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.68e-06	1.05e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	1.68e-06	1.05e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.68e-06	1.05e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	1.67e-06	1.04e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—APOE—Parkinson's disease	1.66e-06	1.03e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.64e-06	1.02e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.62e-06	1.01e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—INS—Parkinson's disease	1.62e-06	1.01e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—TH—Parkinson's disease	1.6e-06	9.95e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	1.57e-06	9.79e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—APOE—Parkinson's disease	1.56e-06	9.74e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	1.56e-06	9.73e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.56e-06	9.72e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	1.54e-06	9.63e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	1.54e-06	9.63e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	1.53e-06	9.57e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.53e-06	9.56e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	1.44e-06	9e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	1.42e-06	8.85e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—INS—Parkinson's disease	1.42e-06	8.83e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	1.37e-06	8.56e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	1.36e-06	8.5e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—COMT—Parkinson's disease	1.36e-06	8.46e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.35e-06	8.42e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.35e-06	8.4e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—INS—Parkinson's disease	1.33e-06	8.32e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.33e-06	8.31e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.28e-06	7.97e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	1.27e-06	7.95e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	1.27e-06	7.9e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	1.26e-06	7.87e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.24e-06	7.74e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.19e-06	7.41e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.17e-06	7.31e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.1e-06	6.84e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	1.09e-06	6.81e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOE—Parkinson's disease	1.02e-06	6.37e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—Parkinson's disease	9.95e-07	6.21e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	9.86e-07	6.15e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	9.21e-07	5.75e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	9.07e-07	5.65e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—INS—Parkinson's disease	8.72e-07	5.44e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	8.05e-07	5.02e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	7.48e-07	4.67e-06	CbGpPWpGaD
